London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Offered 68p to sell. Hell no thanks!
Excellent find Cam! Brilliant in fact!
And now 68 just paid
IMHO DYOR GLA
Looks like its moving up now :-)
https://pbs.twimg.com/media/EZbch7wWAAIPyTp?format=jpg&name=large
bobat wrong board matey
Are you getting confused Boby
Motif Bio plc (AIM: MTFB), which has been reclassified as an AIM Rule 15 cash shell, announces a business update and the appointment of Peel Hunt LLP ("Peel Hunt") as strategic adviser to the Company. Peel Hunt is a specialist investment bank focused on corporate broking, advisory, research, sales and trading and has been engaged to provide guidance to the Directors on strategic initiatives including selecting an appropriate reverse takeover ('RTO') candidate.
The Company is in negotiations with several RTO candidates in the healthcare sector. The Covid-19 pandemic has created new opportunities for companies in the healthcare sector and the RTO candidates under current consideration are exploring ways in which their therapeutic product candidates may help patients with Covid-19. At this stage, there can be no assurance that the Company will be able to agree terms with any RTO candidates or complete a RTO transaction.
Following its reclassification as an AIM Rule 15 cash shell in January 2020, the Company is required to make an acquisition which constitutes a reverse takeover under the AIM Rules by 28 July 2020, failing which the Company's ordinary shares would be suspended from trading on AIM pursuant to AIM Rule 40. The Company's admission to trading on AIM would then be cancelled six months from the date of suspension, should the reason for the suspension not have been rectified.
As previously disclosed, following the recent placing to raise gross proceeds of £650,000 the Company has sufficient working capital until February 2021 and the Directors remain focused on completing a RTO prior to that time.
Jonathan Gold, President and Chief Business Officer of Motif Bio, said: "Following the recent fundraise we are pleased to be in a position where we have several options to evaluate. We are currently working with our advisers to identify the most appropriate RTO candidate for the Company and look forward to providing our shareholders with further updates as appropriate."
The person responsible for the release of this announcement on behalf of Motif Bio is Jonathan Gold, President and Chief Business Officer.
Agree, the build up of news eminating from the consortium members as well as the interview last week has got me thinking that they are ‘ready’. Its a matter of now when do the government want to role this out and make it official. Its as if Abingdon are itching at the bit for this announcement!
Im certain they have been working towards a set deadline which fits with the government strategy. Just a question of when do the government want these tests out there. I am sure the consortium are ready to go
Abingdon Health is mobilising its rapid test development and manufacturing operations in order to scale-up the deployment of rapid diagnostics in response to the global COVID-19 outbreak